|
|
楼主 |
发表于 2022-12-17 20:03:58
|
显示全部楼层
来自： 中国江苏泰州
除了相当年轻的劳动力结构，卡塔尔疫苗接种全球前十，这是他们开放的重要基础也是死亡比流感低的重要原因。下面是详细的疫苗情况，我们拿她的结论来套，就是邯郸学步
卡塔尔卫生部宣布，有清晰的医学证据表明，在接种批准的疫苗的第二针六个月后，抵抗新冠病毒的免疫系统开始逐渐减弱。卡塔尔为了确保本国人口的安全，特将新冠疫苗的有效期从第二针之后的12个月缩短至9个月。
The Ministry of Public Health announced, that there is clear medical evidence that protective immunity from COVID-19 infection begins to decline six months after the second dose of an approved vaccine. The State of Qatar, in order to ensure the health and safety of the population, has changed the vaccine validity of COVID-19 immunity from 12 months to 9 months following the second dose.
该改动的生效日期是2022年2月1日，也就是说在2022年2月1日之前9个月以上接种了辉瑞，莫得那，阿斯利康第二针的将被认为是未接种疫苗，在健康码软件上也就没有了那个金边。
The change comes into effect on 1 February 2022 and means that individuals whose second COVID-19 vaccine dose of Pfizer-BioNTech, Moderna or AstraZeneca was more than 9 months ago on 1 February 2022 will be considered unvaccinated and will lose their Gold Frame (immunized) status on Ehteraz.
接种一针加强针可以恢复金边并保持9个月。这也让卡塔尔同中东区域以及国际的做法同规，共同应对当前的全球大流行。
Receiving a booster vaccine dose will reinstate their Gold Frame status for a further 9 months. This aligns Qatar with the protective actions being taken by other countries in the region and the world, to address the ongoing pandemic. |
|
[复制链接]
发表于 2022-12-17 19:46:26
